Skip to main content
Log in

Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing’s syndrome

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

We have studied the variation of ACTH, cortisol and DHEA-S plasma levels in 6 patients before and up to 15 months after surgical remission of Cushing’s syndrome in order to compare the relative dependency of cortisol and adrenal androgens towards ACTH. Three patients with adrenal adenoma were treated by unilateral adrenalectomy. Three other patients with Cushing’s disease underwent transsphenoidal pituitary tumorectomy. Preoperative ACTH was undetectable in patients with adrenal adenoma and high-normal or elevated in patients with Cushing’s disease. All patients became rapidly hypocortisolemic after surgery and ACTH and cortisol levels eventually recovered at different intervals. Patients with adrenal adenoma had an initially low DHEA-S which failed to normalize for the entire follow-up period. Patients with Cushing’s disease had normal or high-normal DHEA-S which became low immediately after surgery, following ACTH decrease, and it remained low during the entire follow-up period. In conclusion, after removal of corticotropic inhibition secondary to excess cortisol, DHEA-S remains suppressed for a longer period of time than cortisol. Moreover it only takes a short period of relatively low ACTH (after pituitary tumor excision) to induce a long lasting DHEA-S inhibition. Therefore the DHEA-S secreting adrenal cells seem to be more sensitive to the lack of corticotropic stimulation than cortisol secreting cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Avgerinos P.C., Cutler G.B., Jr, Tsokos G.C., Gold P.W., Feuillan P., Gallucci W.T., Pillemer S.R., Loriaux D.L., Chrousos G.P. Dissociation between cortisol and adrenal androgen secretion in patients receiving alternate day prednisone therapy. J. Clin. Endocrinol. Metab. 65: 24, 1987.

    Article  PubMed  CAS  Google Scholar 

  2. Parker L.N., Odell W.D. Evidence for existence of cortical androgen-stimulating hormone. Am. J. Physiol. 236: E616, 1979.

    PubMed  CAS  Google Scholar 

  3. Anderson D.C. The adrenal androgen-stimulating hormone does not exist. Lancet 2: 454, 1980.

    Article  PubMed  CAS  Google Scholar 

  4. Parker L., Lifrak E., Shively J., Lee T., Kaplan B., Walker P., Calaycay J., Florsheim W., Soon-Shiong P. Human adrenal gland cortical androgen-stimulation hormone (CASH) is identical with a portion of the joining peptide of pituitary pro-opiomelanocortin (POMC). 71st Annual Meeting of the Endocrine Society, Seattle, June 21–24, 1989, Abstract 299.

  5. Yamaji T., Ishibashi M., Sekihara H., Itabashi A., Yanaihara T. Serum dehydroepiandrosterone sulfate in Cushing’s syndrome. J. Clin. Endocrinol. Metab. 59: 1164, 1984.

    Article  PubMed  CAS  Google Scholar 

  6. Cutler G.B. Jr., Davis S.E., Johnsonbaugh R.E., Loriaux D.L. Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency. J. Clin. Endocrinol. Metab. 49: 604, 1979.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kleiber, H., Rey, F., Temler, E. et al. Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing’s syndrome. J Endocrinol Invest 14, 489–492 (1991). https://doi.org/10.1007/BF03346848

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346848

Key-words

Navigation